Medecision Announces Strategic Acquisition of Excell Healthcare Advisors, a Nationally-Recognized Healthcare Consultancy

Acquisition further boosts Medecision's ability to deliver critical change management services while elevating service efficiencies and client satisfaction

KING OF PRUSSIA, Pa., Aug. 26, 2025 /PRNewswire/ -- Medecision, the leader in data-driven clinical technology solutions for healthcare organizations, announces the acquisition of Excell Healthcare Advisors (Excell), a premier healthcare consultancy that has a proven track record of supporting healthcare organizations with the transformation of their clinical operations to drive step-function improvements in administrative costs, medical trend, and patient outcomes. This acquisition strengthens both companies' shared expertise and enhances Medecision's services, supporting seamless customer adoption and sustained utilization of essential healthcare technologies.

With over 40 years of experience, Excell has a proven track record of delivering high-quality, measurable results for commercial and government health plans, provider organizations, and life sciences companies. They specialize in helping healthcare organizations achieve tangible ROI and improvements through their clinical, operational, project management, training, and change management services.

"This acquisition bolsters Medecision's ability to deliver additional high value support to organizations that are seeking to maximize the impact and efficiency of their clinical activities," said Kenneth Young, President and CEO of Medecision. "As our customers evolve their clinical operating models and technology platforms, effective organizational alignment, process redesign and change management is critical."

"Throughout the customer journey, from implementation to long-term success, Medecision and Excell will empower organizations to boost performance, inspire innovation, and enhance efficiency," said Shawn Archambault, Co-Founder & Partner at Excell. "This integrated approach will reshape organizational mindsets by aligning people, processes, and technology for full clinical transformation."

Medecision, a subsidiary of Health Care Service Corporation (HCSC), is trusted by leading health organizations, health plans, third-party administrators, and government entities. Its flagship product offerings stand as the market's most extensible clinical data platform, currently supporting the care of over 42 million individuals in the U.S.

About Medecision
Medecision delivers data event-powered solutions that enable risk-bearing organizations to manage care management, utilization management, and population health efficiently and intelligently. Trusted by organizations covering more than 10% of the U.S. population, the Medecision platform provides real-time insights, automation, seamless interoperability, and scalable engagement to help customers improve outcomes while reducing cost and complexity.

About Excell Healthcare Advisors
Excell Healthcare Advisors assists healthcare organizations with developing strategies and action plans to drive step-function improvement in their clinical activities. Services encompass a full spectrum of clinical, operational and change management expertise. Excell aligns all solutions with end-user needs to ensure adoption, utilization, and value-based outcomes.

Media Contact:
John Gonda
[email protected]
616.309.4888

SOURCE Medecision